Company Profile

Myosin Therapeutics Inc
Profile last edited on: 5/22/2023      CAGE: 8SNG6      UEI: MLH1HUK133H3

Business Identifier: Novel medications for CNS-based disorders
Year Founded
2020
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

130 Scripps Way
Jupiter, FL 33458
   (844) 696-7469
   contact@myosintx.com
   www.myosintherapeutics.com
Location: Single
Congr. District: 18
County: Palm Beach

Public Profile

iStructured around addressing significant unmet medical needs and involving a team with decades of experience in hit-to-lead discovery, optimization and therapeutic development to the clinic, Myosin Therapeutics is a biopharmaceutical company developing novel medications targeting cellular motor proteins, specialized molecular machines that convert energy into mechanical work inside cells. Molecular motors are an under-exploited area of disease treatment, including cancer.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2024 2 NIH $1,545,093
Project Title: MT-125 for the Therapeutic Treatment of Glioblastoma
2023 2 NIH $3,182,913
Project Title: Development of a first-in-class nonmuscle myosin II inhibitor to prevent substance use disorder relapse

Key People / Management

  Courtney A Miller -- Co-Founder and President

  Patrick Griffin

  Theodore Kamenecka

  Andrew J Ritter

  Steven S Rosenfeld

  James Schaeffer

  Erica J Young -- Senior Scientific Director.

Company News

There are no news available.